Details for Patent: 7,691,880
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,691,880 protect, and when does it expire?
Patent 7,691,880 protects METHYLIN and is included in one NDA.
This patent has ten patent family members in nine countries.
Summary for Patent: 7,691,880
| Title: | Methylphenidate solution and associated methods of administration and production |
| Abstract: | A methylphenidate solution and associated methods of administration and production, which includes methylphenidate and at least one organic acid dissolved in a solvent system, where the solvent system includes at least one non-aqueous solvent. The solvent system may include water. The non-aqueous solvent can include, but is not limited to polyols and glycols and associated mixtures thereof. Pharmaceutical additives such as flavorings, colorants, buffers, preservatives and mixtures thereof may be optionally added to the methylphenidate solution. |
| Inventor(s): | Herman; Clifford J. (St. Louis, MO) |
| Assignee: | Mallinckrodt Inc. (Hazelwood, MO) |
| Application Number: | 10/554,133 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,691,880 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; |
Drugs Protected by US Patent 7,691,880
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Specgx Llc | METHYLIN | methylphenidate hydrochloride | SOLUTION;ORAL | 021419-001 | Dec 19, 2002 | AA | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Specgx Llc | METHYLIN | methylphenidate hydrochloride | SOLUTION;ORAL | 021419-002 | Dec 19, 2002 | AA | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,691,880
| PCT Information | |||
| PCT Filed | October 07, 2004 | PCT Application Number: | PCT/US2004/033268 |
| PCT Publication Date: | April 21, 2005 | PCT Publication Number: | WO2005/035000 |
International Family Members for US Patent 7,691,880
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 526988 | See Plans and Pricing | |||
| Australia | 2004280240 | See Plans and Pricing | |||
| Canada | 2540052 | See Plans and Pricing | |||
| China | 1867359 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
